Haixiang Cao
-
- Peptidase Inhibition and Analysis 2
- Viral-associated cancers and disorders 1
-
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
-
- Acute Myeloid Leukemia Research 1
-
- Diabetes Treatment and Management 2
- Natural Antidiabetic Agents Studies 1
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Cited by
- OncologyMolecular BiologyHematology
- Journals
- Journal of Clinical Oncology (1 paper)Diabetes Obesity and Metabolism (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Haixiang Cao
4 papers receiving 230 citations
Peers
Comparison fields: 5 of 38
- Oncology 104
- Molecular Biology 193
- Hematology 19
- Pathology and Forensic Medicine 26
- Virology 6
Countries citing papers authored by Haixiang Cao
This map shows the geographic impact of Haixiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixiang Cao more than expected).
Fields of papers citing papers by Haixiang Cao
This network shows the impact of papers produced by Haixiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixiang Cao. The network helps show where Haixiang Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haixiang Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2016 | 127 | |
| 4 | 2012 | 90 | |
| 5 | 2009 | 14 |
About Haixiang Cao
Haixiang Cao is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Hematology, having authored 5 papers that have together received 236 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Peptidase Inhibition and Analysis (2 papers), Protein Degradation and Inhibitors (2 papers), Diabetes Treatment and Management (2 papers), Acute Myeloid Leukemia Research (1 paper), Natural Antidiabetic Agents Studies (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper) and Viral-associated cancers and disorders (1 paper). The work is most often cited by research in Oncology (104 citations), Molecular Biology (193 citations) and Hematology (19 citations). Haixiang Cao has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xianping Lu, Zhiqiang Ning, Xinhao Wang, Zhibin Li, Mei Dong, Guifang Dou, Yuankai Shi, Zhiyun Meng, Feng-yi Feng and Yuankai Shi. Their work appears in journals such as Journal of Clinical Oncology, Diabetes Obesity and Metabolism and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.